Exploring new biological treatments in posterior uveitis

Video
Conference|EURETINA

Quan Dong Nguyen, MD, MSc, FARVO, FASRS, speaks on the highlights of his presentation regarding new biological treatments of posterior uveitis.

Quan Dong Nguyen, MD, MSc, FARVO, FASRS, director of the Uveitis and Ocular Inflammation Service, Byers Eye Institute, Stanford University School of Medicine, speaks on the highlights of his presentation regarding new biological treatments of posterior uveitis.

See more EURETINA coverage


Recent Videos
WIO 2024: An educator's perspective on shattering glass ceilings in ophthalmology
Hannah Chiu, MD, FRCSC, highlights some of the early benefits of an AI-operated telephone call system for postoperative patient care at WIO 2024
Retinal Inner Layer Disorganization and OCT in Uveitic Macular Edema: Insights from Dr. Amitha Domalpally
ARVO 2024: Study Reveals Faricimab's Potential for Extended Dosing in nAMD
Related Content
Phase 2b/3 trial of izokibep in non-infectious, non-anterior uveitis does not meet primary endpoint

Phase 2b/3 trial of izokibep in non-infectious, non-anterior uveitis does not meet primary endpoint

Sydney M Crago
December 11th 2024
Article
Integrating AI to manage DR in a primary care setting

Integrating AI to manage DR in a primary care setting

Alex Delaney-Gesing ;David Hutton
December 1st 2020
Podcast
Excellence across the board at the 2024 Euretina Congress

Excellence across the board at the 2024 Euretina Congress

Hattie Hayes
November 20th 2024
Article
What to expect from virtual AAO 2020

What to expect from virtual AAO 2020

Alex Delaney-Gesing
November 5th 2020
Podcast
GA therapies coming down the pike

GA therapies coming down the pike

Lynda Charters
November 9th 2024
Article
Patient selection for GA therapy

Patient selection for GA therapy

Lynda Charters
November 9th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.